320 related articles for article (PubMed ID: 22733017)
1. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience.
Cowan AJ; Skinner M; Seldin DC; Berk JL; Lichtenstein DR; O'Hara CJ; Doros G; Sanchorawala V
Haematologica; 2013 Jan; 98(1):141-6. PubMed ID: 22733017
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience.
Lim AY; Lee JH; Jung KS; Gwag HB; Kim DH; Kim SJ; Lee GY; Kim JS; Kim HJ; Lee SY; Lee JE; Jeon ES; Kim K
Korean J Intern Med; 2015 Jul; 30(4):496-505. PubMed ID: 26161016
[TBL] [Abstract][Full Text] [Related]
3. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.
Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD
Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234
[TBL] [Abstract][Full Text] [Related]
4. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
5. Localized tongue amyloidosis: a single institutional case series.
O'Reilly A; D'Souza A; Lust J; Price D
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):240-4. PubMed ID: 23715681
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of gastrointestinal symptoms in systemic amyloidosis.
Yen T; Chen FW; Witteles RM; Liedtke M; Nguyen LA
Neurogastroenterol Motil; 2018 Apr; 30(4):e13229. PubMed ID: 29024324
[TBL] [Abstract][Full Text] [Related]
7. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
[TBL] [Abstract][Full Text] [Related]
8. Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution.
Said SM; Grogg KL; Smyrk TC
Hum Pathol; 2015 Apr; 46(4):491-8. PubMed ID: 25649008
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.
Madan S; Dispenzieri A; Lacy MQ; Buadi F; Hayman SR; Zeldenrust SR; Rajkumar SV; Gertz MA; Kumar SK
Mayo Clin Proc; 2010 Mar; 85(3):232-8. PubMed ID: 20194151
[TBL] [Abstract][Full Text] [Related]
10. Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis.
Krauß LU; Schmid S; Mester P; Utpatel K; Kunst C; Müller M; Pavel V
J Gastrointestin Liver Dis; 2023 Dec; 32(4):497-506. PubMed ID: 38147621
[TBL] [Abstract][Full Text] [Related]
11. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.
Nelson LM; Gustafsson F; Gimsing P
Acta Haematol; 2015; 133(4):336-46. PubMed ID: 25531398
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
14. Amyloidosis: review of 236 cases.
Kyle RA; Bayrd ED
Medicine (Baltimore); 1975 Jul; 54(4):271-99. PubMed ID: 1152671
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal amyloidosis].
Lévy A; Lender M
Nouv Presse Med; 1976 Sep; 5(31):1969-73. PubMed ID: 185589
[TBL] [Abstract][Full Text] [Related]
16. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and Management Strategies for GI Involvement with Amyloidosis.
Fritz CDL; Blaney E
Am J Med; 2022 Apr; 135 Suppl 1():S20-S23. PubMed ID: 35077702
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
Rajkumar SV; Gertz MA; Kyle RA
Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
[TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases.
Tsukada N; Ikeda M; Shingaki S; Miyazaki K; Meshitsuka S; Yoshiki Y; Abe Y; Suzuki K
Int J Hematol; 2016 Mar; 103(3):299-305. PubMed ID: 26703787
[TBL] [Abstract][Full Text] [Related]
20. Localized amyloidosis: A diagnostic pitfall in breast pathology.
Lytle A; Darvishian F; Ozerdem U
Pathol Res Pract; 2019 Dec; 215(12):152699. PubMed ID: 31708371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
